Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
Completed
Astra Zeneca Canada
Phase 1
2007-01-01
RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory
from patients receiving budesonide and formoterol may help doctors learn more about the
effect of budesonide and formoterol on gene expression and biomarkers.
PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients
with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung
cancer, or with asthma treated with budesonide and formoterol.
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
Completed
AstraZeneca
Phase 1
2007-01-01
RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory
from patients receiving budesonide and formoterol may help doctors learn more about the
effect of budesonide and formoterol on gene expression and biomarkers.
PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients
with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung
cancer, or with asthma treated with budesonide and formoterol.
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
Completed
British Columbia Cancer Agency
Phase 1
2007-01-01
RATIONALE: Studying the genes expressed in samples of blood and lung fluid in the laboratory
from patients receiving budesonide and formoterol may help doctors learn more about the
effect of budesonide and formoterol on gene expression and biomarkers.
PURPOSE: This clinical trial is studying genes in blood and lung fluid samples from patients
with chronic obstructive pulmonary disease, with or without a previous diagnosis of lung
cancer, or with asthma treated with budesonide and formoterol.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
